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Background
Mutations in presenilins (PS1 and PS2) are the major
cause of familial Alzheimer's disease (FAD). FAD-linked
PS mutations are generally thought to lead to AD patho-
genesis through their property to increase the levels of the
toxic peptide beta-amyloid 42 (Abeta42). Although a
large body of information exists on the biochemistry and
cell biology of presenilins, the normal function of prese-
nilins in the adult mammalian brain has been largely
unknown.
Materials and methods
To overecome the embryonic lethality of PS1/PS2-null
mice, we used the Cre-loxP system to generate PS condi-
tional double knockout (PS cDKO) mice lacking both
presenilins in the postnatal forebrain. Brain morphology
and inflammatory responses in these mice were examined
by histological methods. Investigation of the molecular
events underlying the phenotypes of PS cDKO mice was
performed by quantitative real-time RT-PCR, Western blot
and oligonucleotide microarrays.
Results
PS cDKO mice exhibit impairments of hippocampal
memory and synaptic plasticity which manifest at a young
age (data not shown). These deficits are followed by age-
dependent neurodegeneration and enlargement of the lat-
eral ventricles. Microarray analysis revealed alterations in
the expression of a high number of genes, most notably
up-regulation of a group of inflammatory genes. Strong
astrocytic and microglial activations and high levels of the
inflammatory proteins complement component C1q and
cathepsin S were identified in the brain of PS cDKO mice.
Examination of the CREB/CBP signaling pathway, which
is important for memory formation and neuronal sur-
vival, showed reduced expression of multiple CREB/CBP
target genes in PS cDKO mice, likely mediated through
transcriptional regulation of CBP by Notch signaling,
which is known to be controlled by presenilins.
Discussion
The presence of phenotypes in PS cDKO mice that resem-
ble major characteristics of AD, such as progressive mem-
ory decline and neuronal degeneration, suggest that FAD-
linked PS mutations lead to the pathogenesis of the dis-
ease through a partial loss-of-function mechanism, in
concert with the proposed gain-of-function mechanism
that is responsible for increased production of Abeta42.
The identification that CREB/CBP signaling is regulated
by presenilins, together with previous results showing that
Abeta42 inhibits CREB activation (1, 2) suggest that phar-
macological enhancement of CREB/CBP activity could be
an effective means for therapy of AD.
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